tirzepatide cardiovascular outcomes trial results august 2025 60-Second Journal Club: The SUMMIT examined of treatment with in patients with heart failure with preserved ejection fraction and obesity. Read the full trial Tirzepatide in SURPASS‑CVOT: Favorable Cardiovascular

Most active players and API purchasers alike continue to source from China, making Chinese API supply a central variable in Indias GLP-1 economics regardless of how many domestic brands ultimately reach the market

Clinical oversight depends largely on the individual prescriber's expertise rather than Medvi-specific clinical guidelines

When you start semaglutide, shifts in appetite, nausea, and thirst make hydration an essential part of safe weight loss management and daily medication care

Managing weight loss gradually can help minimize the effects on facial appearance slow and steady weight reduction gives skin more time to retract